375 related articles for article (PubMed ID: 16823703)
1. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
Tanczos BT; Baumgart DC
Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
[No Abstract] [Full Text] [Related]
2. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
3. [Pyoderma gangrenosum--a less well known ulcerous skin disease].
Kostiainen M; Snellman E; Vaalasti A; Rantanen T; Reunala T
Duodecim; 2002; 118(10):1033-7. PubMed ID: 12237998
[No Abstract] [Full Text] [Related]
4. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum.
Triantafillidis JK; Cheracakis P; Sklavaina M; Apostolopoulou K
Scand J Gastroenterol; 2002 Jul; 37(7):863-5. PubMed ID: 12190104
[TBL] [Abstract][Full Text] [Related]
5. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.
Swale VJ; Saha M; Kapur N; Hoffbrand AV; Rustin MH
Clin Exp Dermatol; 2005 Mar; 30(2):134-6. PubMed ID: 15725238
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
[TBL] [Abstract][Full Text] [Related]
9. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
Stichweh DS; Punaro M; Pascual V
Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
[TBL] [Abstract][Full Text] [Related]
10. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
[No Abstract] [Full Text] [Related]
11. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
Nybaek H; Jemec GB
Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
[No Abstract] [Full Text] [Related]
12. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.
Brooklyn TN; Dunnill MG; Shetty A; Bowden JJ; Williams JD; Griffiths CE; Forbes A; Greenwood R; Probert CS
Gut; 2006 Apr; 55(4):505-9. PubMed ID: 16188920
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with infliximab of peristomal pyoderma gangrenosum in ulcerative colitis].
Krag AA; Gjersøe P
Ugeskr Laeger; 2005 May; 167(18):1968-9. PubMed ID: 15929274
[No Abstract] [Full Text] [Related]
14. Management of peristomal pyoderma gangrenosum.
Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
[TBL] [Abstract][Full Text] [Related]
15. Septic shock after treatment of pyoderma gangrenosum with infliximab.
Wölbing F; Fierlbeck G; Hötzenecker W; Schaller M; Röcken M
Acta Derm Venereol; 2009; 89(1):93-4. PubMed ID: 19197554
[No Abstract] [Full Text] [Related]
16. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
Cocco A; Angelucci E; Viscido A; Caprilli R
Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
[No Abstract] [Full Text] [Related]
17. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
18. Six patients with pyoderma gangrenosum successfully treated with infliximab.
Mooij JE; van Rappard DC; Mekkes JR
Int J Dermatol; 2013 Nov; 52(11):1418-20. PubMed ID: 22512250
[No Abstract] [Full Text] [Related]
19. Severe recalcitrant pyoderma gangrenosum treated with infliximab.
Kaur MR; Lewis HM
Br J Dermatol; 2005 Sep; 153(3):689-91. PubMed ID: 16120178
[No Abstract] [Full Text] [Related]
20. Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests.
Uthman I; El-Sayad J; Sharara A
Clin Exp Dermatol; 2005 May; 30(3):294. PubMed ID: 15807693
[No Abstract] [Full Text] [Related]
[Next] [New Search]